As of 2024-12-15, the Fair Value of Algernon Pharmaceuticals Inc (AGN.CN) is -0.64 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.08 CAD, the upside of Algernon Pharmaceuticals Inc is -949.01%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-08-31 | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 5Y Avg | |
| Net income | -1.90 | -8.54 | -7.73 | -6.05 | -6.78 | -6.20 |
| YoY growth | -102.17% | -350.43% | 9.42% | 21.72% | -12.01% | -86.69% |
| Market Cap (mil) | 1.54 |
| P/E | |
| Forward P/E |
| EPS | -0.13 |
| Avg earnings growth rate | -86.69% |
| TTM earnings | -2.61 |